Movie S4 from Intermetastatic and Intrametastatic Heterogeneity Shapes Adaptive Therapy Cycling Dynamics

Movie S4 from Intermetastatic and Intrametastatic Heterogeneity Shapes Adaptive Therapy Cycling Dynamics

<p>Movies corresponding to simulation examples in Figure 6, comparing continuous and adaptive therapy for simulations with intermetastasis and intrametastasis heterogeneity.</p>

Gardado en:

Detalles Bibliográficos
Autor Principal:	Jill Gallaher (16799594) (author)
Outros autores:	Maximilian Strobl (16799597) (author), Jeffrey West (16799600) (author), Robert Gatenby (14962842) (author), Jingsong Zhang (15037632) (author), Mark Robertson-Tessi (14936489) (author), Alexander R.A. Anderson (14936498) (author)
Publicado:	2025
Subjects:	Cancer Tumor Biology Molecular and Cellular Biology Cancer Detection and Diagnosis Therapeutic Research and Development Clinical Research and Trials Methods and Technology Biomarkers Metastasis biomarkers Computational Methods Mathematical modeling Drug Resistance Precision Medicine Progression, Invasion & Metastasis Metastasis Systems Biology Tumor Evolution Tumor Heterogeneity
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares

Movie S1 from Intermetastatic and Intrametastatic Heterogeneity Shapes Adaptive Therapy Cycling Dynamics
por: Jill Gallaher (16799594)
Publicado: (2025)

Movie S2 from Intermetastatic and Intrametastatic Heterogeneity Shapes Adaptive Therapy Cycling Dynamics
por: Jill Gallaher (16799594)
Publicado: (2025)

Movie S3 from Intermetastatic and Intrametastatic Heterogeneity Shapes Adaptive Therapy Cycling Dynamics
por: Jill Gallaher (16799594)
Publicado: (2025)

Supplementary Table 5_Marker genes all and some per cluster no cell cycle_GO and curated pathways per cluster no cell cycle from A Rare Subset of Primary Tumor Cells with Concomitant Hyperactivation of Extracellular Matrix Remodeling and dsRNA-IFN1 Signaling Metastasizes in Breast Cancer
por: Niccolò Roda (16437288)
Publicado: (2025)

Figure 1 from VCAM-1–targeted MRI Improves Detection of the Tumor-brain Interface
por: Vinton W.T. Cheng (15020397)
Publicado: (2025)

Figure 2 from VCAM-1–targeted MRI Improves Detection of the Tumor-brain Interface
por: Vinton W.T. Cheng (15020397)
Publicado: (2025)

Figure 3 from VCAM-1–targeted MRI Improves Detection of the Tumor-brain Interface
por: Vinton W.T. Cheng (15020397)
Publicado: (2025)

Figure 4 from VCAM-1–targeted MRI Improves Detection of the Tumor-brain Interface
por: Vinton W.T. Cheng (15020397)
Publicado: (2025)

Figure 5 from VCAM-1–targeted MRI Improves Detection of the Tumor-brain Interface
por: Vinton W.T. Cheng (15020397)
Publicado: (2025)

Figure 6 from VCAM-1–targeted MRI Improves Detection of the Tumor-brain Interface
por: Vinton W.T. Cheng (15020397)
Publicado: (2025)

Supplementary Table 1_Primer and shRNA sequences_PCR cycles_Mycoplasma testing from A Rare Subset of Primary Tumor Cells with Concomitant Hyperactivation of Extracellular Matrix Remodeling and dsRNA-IFN1 Signaling Metastasizes in Breast Cancer
por: Niccolò Roda (16437288)
Publicado: (2025)

Supplementary file 3: Supplementary Tables. from circFNDC3B Accelerates Vasculature Formation and Metastasis in Oral Squamous Cell Carcinoma
por: Xiang Li (15386727)
Publicado: (2025)

Figure S1 from Estimation of Neutral Mutation Rates and Quantification of Somatic Variant Selection Using cancereffectsizeR
por: Jeffrey D. Mandell (14963909)
Publicado: (2025)

Supplementary Table 10_Pro metastatic pathways identified by classification analysis from A Rare Subset of Primary Tumor Cells with Concomitant Hyperactivation of Extracellular Matrix Remodeling and dsRNA-IFN1 Signaling Metastasizes in Breast Cancer
por: Niccolò Roda (16437288)
Publicado: (2025)

Supplementary Table 2_Predictive power of genes and signatures_Patient cohorts GEO accession number from A Rare Subset of Primary Tumor Cells with Concomitant Hyperactivation of Extracellular Matrix Remodeling and dsRNA-IFN1 Signaling Metastasizes in Breast Cancer
por: Niccolò Roda (16437288)
Publicado: (2025)

Supplementary Table 3_Clonal distribution analysis from A Rare Subset of Primary Tumor Cells with Concomitant Hyperactivation of Extracellular Matrix Remodeling and dsRNA-IFN1 Signaling Metastasizes in Breast Cancer
por: Niccolò Roda (16437288)
Publicado: (2025)

Supplementary Table 4_Marker genes all and some per cluster_GO and curated pathways per cluster from A Rare Subset of Primary Tumor Cells with Concomitant Hyperactivation of Extracellular Matrix Remodeling and dsRNA-IFN1 Signaling Metastasizes in Breast Cancer
por: Niccolò Roda (16437288)
Publicado: (2025)

Supplementary Table 6_Gene modules analysis_GO and curated pathways associated to gene modules from A Rare Subset of Primary Tumor Cells with Concomitant Hyperactivation of Extracellular Matrix Remodeling and dsRNA-IFN1 Signaling Metastasizes in Breast Cancer
por: Niccolò Roda (16437288)
Publicado: (2025)

Supplementary Table 7_Genes identified by differential expression analysis in pro vs non metastatic clones from A Rare Subset of Primary Tumor Cells with Concomitant Hyperactivation of Extracellular Matrix Remodeling and dsRNA-IFN1 Signaling Metastasizes in Breast Cancer
por: Niccolò Roda (16437288)
Publicado: (2025)

Supplementary Table 8_Genes identified by classification analysis in pro vs non metastatic clones from A Rare Subset of Primary Tumor Cells with Concomitant Hyperactivation of Extracellular Matrix Remodeling and dsRNA-IFN1 Signaling Metastasizes in Breast Cancer
por: Niccolò Roda (16437288)
Publicado: (2025)

Supplementary Table 9_Pro metastatic pathways identified by differential expression singlePT setting from A Rare Subset of Primary Tumor Cells with Concomitant Hyperactivation of Extracellular Matrix Remodeling and dsRNA-IFN1 Signaling Metastasizes in Breast Cancer
por: Niccolò Roda (16437288)
Publicado: (2025)

TS1-9 from Dynamics of Sequence and Structural Cell-Free DNA Landscapes in Small-Cell Lung Cancer
por: Lavanya Sivapalan (15314248)
Publicado: (2025)

Figure 1 from Spatially Resolved Transcriptomics Deconvolutes Prognostic Histological Subgroups in Patients with Colorectal Cancer and Synchronous Liver Metastases
por: Colin S. Wood (15293247)
Publicado: (2025)

Figure 2 from Spatially Resolved Transcriptomics Deconvolutes Prognostic Histological Subgroups in Patients with Colorectal Cancer and Synchronous Liver Metastases
por: Colin S. Wood (15293247)
Publicado: (2025)

Figure 3 from Spatially Resolved Transcriptomics Deconvolutes Prognostic Histological Subgroups in Patients with Colorectal Cancer and Synchronous Liver Metastases
por: Colin S. Wood (15293247)
Publicado: (2025)

Figure 4 from Spatially Resolved Transcriptomics Deconvolutes Prognostic Histological Subgroups in Patients with Colorectal Cancer and Synchronous Liver Metastases
por: Colin S. Wood (15293247)
Publicado: (2025)

Figure 5 from Spatially Resolved Transcriptomics Deconvolutes Prognostic Histological Subgroups in Patients with Colorectal Cancer and Synchronous Liver Metastases
por: Colin S. Wood (15293247)
Publicado: (2025)

Figure 6 from Spatially Resolved Transcriptomics Deconvolutes Prognostic Histological Subgroups in Patients with Colorectal Cancer and Synchronous Liver Metastases
por: Colin S. Wood (15293247)
Publicado: (2025)

Supplementary Table 4: SpatialDecon derived immune cell counts from Spatially Resolved Transcriptomics Deconvolutes Prognostic Histological Subgroups in Patients with Colorectal Cancer and Synchronous Liver Metastases
por: Colin S. Wood (15293247)
Publicado: (2025)

Supplementry Table 3: REACTOME Gene Set Enrichment Analysis results from Spatially Resolved Transcriptomics Deconvolutes Prognostic Histological Subgroups in Patients with Colorectal Cancer and Synchronous Liver Metastases
por: Colin S. Wood (15293247)
Publicado: (2025)

Table 1 from Spatially Resolved Transcriptomics Deconvolutes Prognostic Histological Subgroups in Patients with Colorectal Cancer and Synchronous Liver Metastases
por: Colin S. Wood (15293247)
Publicado: (2025)

Supplementary Data from Active Remodeling of Capillary Endothelium via Cancer Cell–Derived MMP9 Promotes Metastatic Brain Colonization
por: Matthia A. Karreman (15097355)
Publicado: (2025)

Supplementary Data from Active Remodeling of Capillary Endothelium via Cancer Cell–Derived MMP9 Promotes Metastatic Brain Colonization
por: Matthia A. Karreman (15097355)
Publicado: (2025)

Supplementary Data from Active Remodeling of Capillary Endothelium via Cancer Cell–Derived MMP9 Promotes Metastatic Brain Colonization
por: Matthia A. Karreman (15097355)
Publicado: (2025)

Supplementary Data from Active Remodeling of Capillary Endothelium via Cancer Cell–Derived MMP9 Promotes Metastatic Brain Colonization
por: Matthia A. Karreman (15097355)
Publicado: (2025)

Supplementary Data from Active Remodeling of Capillary Endothelium via Cancer Cell–Derived MMP9 Promotes Metastatic Brain Colonization
por: Matthia A. Karreman (15097355)
Publicado: (2025)

Supplementary Data from Active Remodeling of Capillary Endothelium via Cancer Cell–Derived MMP9 Promotes Metastatic Brain Colonization
por: Matthia A. Karreman (15097355)
Publicado: (2025)

Supplementary Figure S1 from Evaluation of a Liquid Biopsy-Breast Cancer Methylation (LBx-BCM) Cartridge Assay for Predicting Early Disease Progression and Survival: TBCRC 005 Prospective Trial
por: Kala Visvanathan (14952973)
Publicado: (2025)

Supplementary Figure S2 from Evaluation of a Liquid Biopsy-Breast Cancer Methylation (LBx-BCM) Cartridge Assay for Predicting Early Disease Progression and Survival: TBCRC 005 Prospective Trial
por: Kala Visvanathan (14952973)
Publicado: (2025)

Supplementary Figure S3 from Evaluation of a Liquid Biopsy-Breast Cancer Methylation (LBx-BCM) Cartridge Assay for Predicting Early Disease Progression and Survival: TBCRC 005 Prospective Trial
por: Kala Visvanathan (14952973)
Publicado: (2025)

Cannot write session to /tmp/vufind_sessions/sess_3bhlba0e9tbdeont88ikkosv8l